Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: A Southwest Oncology Group study (S0336)

Robert P. Whitehead, Cathryn Rankin, Paulo M.G. Hoff, Philip J. Gold, Kevin G. Billingsley, Robert A. Chapman, Lucas Wong, John H. Ward, James L. Abbruzzese, Charles D. Blanke

Research output: Contribution to journal › Article › peer-review

72 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: A Southwest Oncology Group study (S0336)'. Together they form a unique fingerprint.

Medicine & Life Sciences